Fumio Nanishi
- Nephrology top 5%
- Cardiology and Cardiovascular Medicine
- Molecular Biology
- Surgery
- Pulmonary and Respiratory Medicine
- Co-authors
- Kaoru OnoyamaSeiya OkudaMasatoshi FujishimaMasakazu WashioYukinori OhHideki HirakataSetsuro IbayashiHiroyuki HIRAKATA
- Topics
- Renal Diseases and Glomerulopathies (5 papers)Chronic Kidney Disease and Diabetes (4 papers)Dialysis and Renal Disease Management (3 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Fumio Nanishi
28 papers receiving 292 citations
Peers
Comparison fields: 5 of 67
- Nephrology 139
- Cardiology and Cardiovascular Medicine 61
- Molecular Biology 55
- Surgery 40
- Pulmonary and Respiratory Medicine 39
Countries citing papers authored by Fumio Nanishi
This map shows the geographic impact of Fumio Nanishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Nanishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Nanishi more than expected).
Fields of papers citing papers by Fumio Nanishi
This network shows the impact of papers produced by Fumio Nanishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Nanishi. The network helps show where Fumio Nanishi may publish in the future.
Co-authorship network of co-authors of Fumio Nanishi
This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Nanishi. A scholar is included among the top collaborators of Fumio Nanishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Nanishi. Fumio Nanishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | 0 | |
| 4 | 18 | |
| 5 | 16 | |
| 6 | 44 | |
| 7 | Clinicopathological study of poststreptococcal glomerulonephritis in the elderly. | 11 |
| 8 | 1 | |
| 9 | 4 | |
| 10 | Effects of anti-hyperlipidaemic agent or dietary protein restriction on progressive renal deterioration in adriamycin-induced nephropathy in rats. | 6 |
| 11 | 11 | |
| 12 | Pharmacokinetic properties of a new angiotensin converting enzyme inhibitor, altiopril calcium, in normal healthy volunteers and patients with renal dysfunction | 3 |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | Recurrence of Henoch Schoenlein purpura nephritis associated with tuberculous pleuritis. | 4 |
| 17 | 21 | |
| 18 | 12 | |
| 19 | Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients. | 7 |
| 20 | 22 |
About Fumio Nanishi
Fumio Nanishi is a scholar working on Nephrology, Rheumatology and Biochemistry, having authored 31 papers that have together received 313 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Dialysis and Renal Disease Management (3 papers). The work is most often cited by research in Nephrology (139 citations), Hematology (38 citations) and Cardiology and Cardiovascular Medicine (61 citations). Fumio Nanishi has collaborated with scholars based in Japan and United States. Frequent co-authors include Kaoru Onoyama, Seiya Okuda, Masatoshi Fujishima, Masakazu Washio, Yukinori Oh, Hideki Hirakata, Setsuro Ibayashi, Hiroyuki HIRAKATA, Takesumi Yoshimura and M Fujishima. Their work appears in journals such as Life Sciences, Clinical Pharmacology & Therapeutics and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.